On February 7, 2024, we initiated a strategic restructuring to align financial, business and research and development objectives for long-term growth, including a reduction-in-force affecting approximately 10% of our employees. We incurred restructuring charges of $1.8 million for employee terminations benefits, including equity modification expense for the three months ended March 31, 2024. Accrued restructuring charges are included in accrued and other current liabilities on the condensed consolidated balance sheet.

A summary of accrued restructuring costs as of March 31, 2024 is shown in the table below (in thousands):


	Three months ended March 31, 2024
Restructuring costs		1,812
Non cash payments		(366	)
Cash payments		(852	)
Accrued restructuring costs as of March 31, 2024	$	594